Scenic City Neurotherapy and Ketamine Center
7405 Shallowford Road, STE 240, Chattanooga
4.9(85 Google reviews)
United States
6 listed treatment centers serving Chattanooga and the surrounding area.
7405 Shallowford Road, STE 240, Chattanooga
4.9(85 Google reviews)
8 Francis Street, Chattanooga
For people in Chattanooga considering SPRAVATO®, the total cost depends on insurance benefits, the treatment setting, and the prescribed schedule. Ask about both the medication and the supervised treatment visit: the medication and required observation and monitoring may be billed separately. A medication benefit alone does not tell you what the whole visit will cost.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medicines you took, how long you took them, and how you responded. Ask the treatment center who gathers those records, submits the authorization request, and follows up if more information is needed.
Medicare may cover Spravato through Part B or Part D depending on the plan and setting. Tennessee Medicaid coverage also depends on the plan and its requirements. Neither program guarantees coverage at a particular center; confirm both your benefits and whether the center accepts your coverage.
Manufacturer savings programs exist for eligible commercially insured patients, but eligibility rules apply and these programs are not for people using government insurance. Ask about current terms rather than assuming you qualify.
Before starting, ask the center and insurer:
Include transportation and time away from work in your planning, too.
SPRAVATO® treatment requires in-person visits to a REMS-certified healthcare setting. You self-administer the nasal spray under direct observation; it is never sent home for you to use on your own.
This directory currently has no listed treatment center in Chattanooga. The supplied listings include Collegedale as a nearby city to investigate, but REMS certification is not confirmed in that listing. Contact a prospective center directly to verify certification, whether it is accepting patients, and insurance participation before arranging travel. A directory listing alone does not establish that a location can provide treatment.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits for weeks 1–4, followed by weekly visits for weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber individualizes the schedule, so do not assume your visits will follow a fixed long-term pattern.
Allow at least two hours for monitoring after each dose, plus time for check-in, preparation, and travel. You may need longer observation before the care team determines you are ready to leave. Ask about appointment availability before requesting time off work or arranging caregiving.
You need someone else to drive you home. Do not drive or operate machinery until the next day after a restful sleep. Arrange reliable rides for every appointment, identify a backup driver, and ask the center about its pickup and transportation requirements. If rides or work hours make attendance difficult, discuss those barriers before starting rather than skipping or changing visits on your own.
This directory currently has no listed center in Chattanooga. Collegedale appears in the supplied listings, but its listing does not confirm REMS certification. Before booking an evaluation, ask whether the treatment location is currently REMS-certified to provide Spravato, is accepting new patients, and can work with your insurance. Do not treat a directory entry as confirmation of certification or availability.
Spravato is FDA-approved for adults with treatment-resistant depression, alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and medical risks to decide whether it is appropriate for you.
Coverage depends on your plan, the treatment setting, and authorization requirements. Insurers commonly request documentation of previous antidepressant trials. Medicare and Tennessee Medicaid may cover treatment depending on the plan and setting, but coverage and a center’s acceptance of your insurance are separate questions. Ask about both medication and monitoring charges, and request a written estimate before starting.
You use the nasal spray yourself under a healthcare provider’s direct observation in a REMS-certified setting. Staff monitor you for at least two hours after the dose, including watching for sedation, dissociation, breathing problems, and increased blood pressure. Plan for additional appointment and travel time. Someone else must take you home, and you cannot drive until the next day after a restful sleep.
Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. Dissociation can feel like being disconnected from yourself or your surroundings. Blood pressure can also rise. Spravato is a Schedule III controlled substance. Review your medical history, medicines, and substance-use history with the clinician, and tell staff immediately about concerning symptoms during monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Do not wait for a treatment appointment if you need immediate help. Call or text 988 for crisis support, or call 911 in an emergency. A clinician can assess what level of care is needed now.
Approved uses, nearby treatment centers, and medically sourced patient guides.